OncoPharm
John Bossaer
Add to My Podcasts
Episodes
About
Reviews
Promote
Zanubrutinib
20 minutes
Posted Nov 21, 2019 at 2:30 pm.
0:00
20:29
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
BTK-targeting therapy approved again! Zanubrutinib approved for Mantle Cell Lymphoma (2nd line) - how does it compare to ibrutinib and acalabrutinib?
Previous
Immunotherapy Interactions
Next
Cornucopia Of OncoPharm Updates
← See all 273 episodes of OncoPharm